ACH
ZYME icon

ArrowMark Colorado Holdings’s Zymeworks ZYME Stock Holding History

ArrowMark Colorado Holdings’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-25,000
Closed -$887K – 327
2020
Q1 		$887K Buy
+25,000
New +$1.02M 0.01% 254

Other funds holding ZYME

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

ArrowMark Colorado Holdings's ZYME Position: Q2 2020 in Review

ArrowMark Colorado Holdings sold out of Zymeworks (ZYME) in Q2 2020, closing a stake of 25,000 shares — an estimated $887K sold.

ArrowMark Colorado Holdings first reported a position in ZYME in Q1 2020 and held it in 1 quarter. The position peaked at $887K in Q1 2020. 133 funds tracked by Wall St. Rank hold ZYME as of Q2 2020.

  • ArrowMark Colorado Holdings reported no remaining Zymeworks position as of Q2 2020 after selling out during the quarter.
  • ArrowMark Colorado Holdings sold 25,000 Zymeworks shares in Q2 2020, an estimated $887K.
  • ArrowMark Colorado Holdings first reported a position in Zymeworks in Q1 2020 and held it in 1 quarter.
  • ArrowMark Colorado Holdings's Zymeworks position peaked at $887K in Q1 2020.
  • 133 funds tracked by Wall St. Rank held Zymeworks as of Q2 2020.

Based on ArrowMark Colorado Holdings's 13F filing for Q2 2020, filed 14 Aug 2020.